Intratracheal instillation of cerium oxide nanoparticles induces hepatic toxicity in male Sprague-Dawley rats (2011) Nalabotu SK, Kolli MB, Triest WE, Ma JY, Manne NDPK, Katta A, Addagarla HS, Rice KM, Blough ER International Journal of Nanomedicine Volume 2011:6 Pages 2327 – 2335

Comparison of the course of biomarker changes and kidney injury in a rat model of drug-induced acute kidney injury (2011) Sasaki D, Yamada A, Umeno H, Kurihara H, Nakatsuji S, Fujihira S, Tsubota K, Ono M, Moriguchi A, Watanabe K, Seki J Biomarkers. 2011 Sep 28. [Epub ahead of print]

Urinary cystatin C as a biomarker for acute kidney injury and its immunohistochemical localization in kidney in the CDDP-treated rats (2011) Togashi Y, Sakaguchi Y, Miyamoto M, Miyamoto Y Exp Toxicol Pathol. 2011 Mar 4. [Epub ahead of print]

Lower urinary connective tissue growth factor levels and incident CKD stage 3 in the general population (2011) O’Seaghdha CM, Hwang SJ, Bhavsar NA, Köttgen A, Coresh J, Astor BC, Fox CS Am J Kidney Dis. 2011 Jun;57(6):841-9

Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease (2011) Zhang L, Rajan V, Lin E, Hu Z, Han HQ, Zhou X, Song Y, Min H, Wang X, Du J, Mitch WE FASEB J. 2011 May;25(5):1653-63

Trefoil Factor 3 Predicts Incident Chronic Kidney Disease: A Case-Control Study Nested within the Atherosclerosis Risk in Communities (ARIC) Study (2011) Astor BC, Köttgen A, Hwang SJ, Bhavsar N, Fox CS, Coresh J Am J Nephrol. 2011 Aug 9;34(4):291-297.

Clinical and Plasma Proteomic Markers Correlating With Chronic Kidney Disease After Liver Transplantation (2011) Levitsky J, Salomon DR, Abecassis M, Langfelder P, Horvath S, Friedewald J, Wang E, Kurian SM, Mondala T, Gil S, McDade R, Ballard K, Gallon L Am J Transplant. 2011 Jul 27.

Urinary biomarkers in hexachloro-1:3-butadiene-induced acute kidney injury in the female Hanover Wistar rat; correlation of a-glutathione S-transferase, albumin and kidney injury molecule-1 with histopathology and gene expression (2011) Swain A, Turton J, Scudamore CL, Pereira I, Viswanathan N, Smyth R, Munday M, McClure F, Gandhi M, Sondh S, York M J Appl Toxicol. [Epub ahead of print]

Assessment of Biomarkers of Drug-induced Kidney Injury in Cynomolgus Monkeys Treated with a Triple Re-uptake Inhibitor (2011) Guha M, Heier A, Price S, Bielenstein M, Caccese RG, Heathcote DI, Simpson TR, Stong DB, Bodes E Toxicol Sci. 2011 Jan 22. [Epub ahead of print]

The Role of Residual Gadolinium in the Induction of Nephrogenic Systemic Fibrosis-Like Skin Lesions in Rats (2011) Pietsch H, Raschke M, Ellinger-Ziegelbauer H, Jost G, Walter J, Frenzel T, Lenhard D, Hütter J, Sieber MA Invest Radiol. 46: 48-56.

A panel of urinary biomarkers to monitor reversibility of renal injury and a serum marker with improved potential to assess renal function (2010) Ozer JS, Dieterle F, Troth S, Perentes E, Cordier A, Verdes P, Staedtler F, Mahl A, Grenet O, Roth DR, Wahl D, Legay F, Holder D, Erdos Z, Vlasakova K, Jin H, Yu Y, Muniappa N, Forest T, Clouse HK, Reynolds S, Bailey WJ, Thudium DT, Topper MJ, Skopek TR, Sina JF, Glaab WE, Vonderscher J, Maurer G, Chibout SD, Sistare FD, Gerhold DL Nat Biotechnol.28: 444-5.

A guidance for renal biomarker lead optimization and use in translational pharmacodynamics (2010) Ozer JS Drug Discov Today15: 142-7.

Uromodulin levels associate with a common UMOD variant and risk for incident CKD (2010) Köttgen A, Hwang SJ, Larson MG, Van Eyk JE, Fu Q, Benjamin EJ, Dehghan A, Glazer NL, Kao WH, Harris TB, Gudnason V, Shlipak MG, Yang Q, Coresh J, Levy D, Fox CS J Am Soc Nephrol 21: 337-344.

Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies (2010) Vaidya VS, Ozer JS, Dieterle F, Collings FB, Ramirez V, Troth S, Muniappa N, Thudium D, Gerhold D, Holder DJ, Bobadilla NA, Marrer E, Perentes E, Cordier A, Vonderscher J, Maurer G, Goering PL, Sistare FD, Bonventre JV Nat Biotechnol. 28: 478-85.

Recommendations to qualify biomarker candidates of drug-induced liver injury (2010) Ozer JS, Chetty R, Kenna G, Koppiker N, Karamjeet P, Li D, Palandra J, Lanevschi A, Souberbielle BE, Ramaiah S Biomark Med 4: 475-483.

Urinary clusterin, cystatin C, ß2-microglobulin and total protein as markers to detect drug-induced kidney injury (2010) Dieterle F, Perentes E, Cordier A, Roth DR, Verdes P, Grenet O, Pantano S, Moulin P, Wahl D, Mahl A, End P, Staedtler F, Legay F, Carl K, Laurie D, Chibout SD, Vonderscher J, Maurer G Nat Biotechnol 28: 463-469.

The involvement of pro-inflammatory cytokines in nephrogenic systemic fibrosis – a mechanistic hypothesis based on preclinical results from a rat model treated with gadodiamide. (2009) Steger-Hartmann T, Raschke M, Riefke B, Pietsch H, Sieber MA, Walter J Exp Toxicol Pathol 61: 537-552.

Analysis of Renal Biomarkers in Samples of Rat Urine Samples Frozen for 44 months From a Study on Puromycin Amino Nucleoside (PAN) (2009) Perron MF, Burnett R, Reiniche A, Briffaux JP, Eisinger D, Küsters S and Mapes J Toxicology LettersVolume 189, Supplement 1, S159

Distinct functions of activated protein C differentially attenuate acute kidney injury (2009) Gupta A, Gerlitz B, Richardson MA, Bull C, Berg DT, Syed S, Galbreath EJ, Swanson BA, Jones BE, Grinnell BW J Am Soc Nephrol. 20: 267-77.

The Liver Toxicity Biomarker Study: Phase I Design and Preliminary Results. (2009) McBurney RN, Hines WM, Von Tungeln LS, Schnackenberg LK, Beger RD, Moland CL, Han T, Fuscoe JC, Chang CW, Chen JJ, Su Z, Fan XH, Tong W, Booth SA, Balasubramanian R, Courchesne PL, Campbell JM, Graber A, Guo Y, Juhasz PJ, Li TY, Lynch MD, Morel NM, Plasterer TN, Takach EJ, Zeng C, Beland FA Toxicol Pathol 37: 52-64.

Endothelial activation markers in anemic non-dialysis chronic kidney disease patients. (2008) Patel TV, Mittal BV, Keithi-Reddy SR, Duffield JS, Singh AK Nephron Clin Pract 110: c244-250.

Tissue distribution and toxicity of intravenously administered titanium dioxide nanoparticles in rats. (2008) Fabian E, Landsiedel R, Ma-Hock L, Wiench K, Wohlleben W, van Ravenzwaay B Arch Toxicol 82: 151-157.

Activated protein C ameliorates LPS-induced acute kidney injury and downregulates renal INOS and angiotensin 2. (2007) Gupta A, Rhodes GJ, Berg DT, Gerlitz B, Molitoris BA, Grinnell BW Am J Physiol Renal Physiol 293: F245-F254.